207 related articles for article (PubMed ID: 26579829)
1. Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.
Lucarelli G; Rutigliano M; Sanguedolce F; Galleggiante V; Giglio A; Cagiano S; Bufo P; Maiorano E; Ribatti D; Ranieri E; Gigante M; Gesualdo L; Ferro M; de Cobelli O; Buonerba C; Di Lorenzo G; De Placido S; Palazzo S; Bettocchi C; Ditonno P; Battaglia M
Medicine (Baltimore); 2015 Nov; 94(46):e2117. PubMed ID: 26579829
[TBL] [Abstract][Full Text] [Related]
2. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Kathagen-Buhmann A; Maire CL; Weller J; Schulte A; Matschke J; Holz M; Ligon KL; Glatzel M; Westphal M; Lamszus K
Neuro Oncol; 2018 Nov; 20(12):1594-1605. PubMed ID: 30053149
[TBL] [Abstract][Full Text] [Related]
3. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
6. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
8. Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma.
Lucarelli G; Rutigliano M; Ferro M; Giglio A; Intini A; Triggiano F; Palazzo S; Gigante M; Castellano G; Ranieri E; Buonerba C; Terracciano D; Sanguedolce F; Napoli A; Maiorano E; Morelli F; Ditonno P; Battaglia M
Urol Oncol; 2017 Jul; 35(7):461.e15-461.e27. PubMed ID: 28359744
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma.
Kim B; Jung M; Moon KC
Dis Markers; 2019; 2019():1342161. PubMed ID: 31481981
[TBL] [Abstract][Full Text] [Related]
12. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
Jiang WG; Raz A; Douglas-Jones A; Mansel RE
J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
[TBL] [Abstract][Full Text] [Related]
13. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
Joseph RW; Kapur P; Serie DJ; Eckel-Passow JE; Parasramka M; Ho T; Cheville JC; Frenkel E; Rakheja D; Brugarolas J; Parker A
Cancer; 2014 Apr; 120(7):1059-67. PubMed ID: 24382589
[TBL] [Abstract][Full Text] [Related]
14. Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma.
Gigante M; Lucarelli G; Divella C; Netti GS; Pontrelli P; Cafiero C; Grandaliano G; Castellano G; Rutigliano M; Stallone G; Bettocchi C; Ditonno P; Gesualdo L; Battaglia M; Ranieri E
Medicine (Baltimore); 2015 Nov; 94(45):e1917. PubMed ID: 26559258
[TBL] [Abstract][Full Text] [Related]
15. High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
Jin Q; Dai Y; Wang Y; Zhang S; Liu G
J Clin Pathol; 2019 May; 72(5):354-362. PubMed ID: 30819726
[TBL] [Abstract][Full Text] [Related]
16. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
17. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
[TBL] [Abstract][Full Text] [Related]
18. BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC).
Pesta M; Travnicek I; Kulda V; Windrichova J; Rezackova H; Houfkova K; Macanova T; Bendova B; Nestorova A; Hes O; Hora M; Topolcan O; Polivka J
Anticancer Res; 2021 Sep; 41(9):4463-4470. PubMed ID: 34475070
[TBL] [Abstract][Full Text] [Related]
19. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
20. FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis.
Zhang Y; Zhu X; Qiao X; Sun L; Tian Y; Yang Y; Zhao Y; Liu C
Int J Med Sci; 2020; 17(17):2819-2825. PubMed ID: 33162809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
